BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 1651083)

  • 21. Cytosolic and membrane-bound cyclic nucleotide phosphodiesterases from guinea pig cardiac ventricles.
    Muller B; Stoclet JC; Lugnier C
    Eur J Pharmacol; 1992 Mar; 225(3):263-72. PubMed ID: 1325367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of theophylline and rolipram on leukotriene C4 (LTC4) synthesis and chemotaxis of human eosinophils from normal and atopic subjects.
    Tenor H; Hatzelmann A; Church MK; Schudt C; Shute JK
    Br J Pharmacol; 1996 Aug; 118(7):1727-35. PubMed ID: 8842438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of isoenzyme-selective PDE inhibitors on methacholine-induced contraction of guinea-pig and rat ileum.
    Tomkinson A; Raeburn D
    Br J Pharmacol; 1996 Aug; 118(8):2131-9. PubMed ID: 8864552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of type-selective phosphodiesterase inhibitors on glucose-induced insulin secretion and islet phosphodiesterase activity.
    Shafiee-Nick R; Pyne NJ; Furman BL
    Br J Pharmacol; 1995 Aug; 115(8):1486-92. PubMed ID: 8564209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Porcine detrusor cyclic nucleotide phosphodiesterase isoenzymes: characterization and functional effects of various phosphodiesterase inhibitors in vitro.
    Truss MC; Uckert S; Stief CG; Schulz-Knappe P; Hess R; Forssmann WG; Jonas U
    Urology; 1995 May; 45(5):893-901. PubMed ID: 7747383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors.
    Willette RN; Shiloh AO; Sauermelch CF; Sulpizio A; Michell MP; Cieslinski LB; Torphy TJ; Ohlstein EH
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):210-9. PubMed ID: 9040501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro pharmacology of the novel phosphodiesterase type 4 inhibitor, CP-80633.
    Cohan VL; Showell HJ; Fisher DA; Pazoles CJ; Watson JW; Turner CR; Cheng JB
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1356-61. PubMed ID: 8819523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Requirement of additional adenylate cyclase activation for the inhibition of human eosinophil degranulation by phosphodiesterase IV inhibitors.
    Ezeamuzie CI
    Eur J Pharmacol; 2001 Apr; 417(1-2):11-8. PubMed ID: 11301054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclic nucleotide phosphodiesterases from frog atrial fibers: isolation and drug sensitivities.
    Lugnier C; Gauthier C; Le Bec A; Soustre H
    Am J Physiol; 1992 Mar; 262(3 Pt 2):H654-60. PubMed ID: 1373036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Compartmentalization of cAMP signaling in mesangial cells by phosphodiesterase isozymes PDE3 and PDE4. Regulation of superoxidation and mitogenesis.
    Chini CC; Grande JP; Chini EN; Dousa TP
    J Biol Chem; 1997 Apr; 272(15):9854-9. PubMed ID: 9092521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective inhibition of a high affinity type IV cyclic AMP phosphodiesterase in bovine trachealis by AH 21-132. Relevance to the spasmolytic and anti-spasmogenic actions of AH 21-132 in the intact tissue.
    Giembycz MA; Barnes PJ
    Biochem Pharmacol; 1991 Jul; 42(3):663-77. PubMed ID: 1650218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of relaxant responses evoked by a nitric oxide donor and by nonadrenergic, noncholinergic stimulation by isozyme-selective phosphodiesterase inhibitors in guinea pig trachea.
    Ellis JL; Conanan ND
    J Pharmacol Exp Ther; 1995 Mar; 272(3):997-1004. PubMed ID: 7891355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta.
    Lugnier C; Schoeffter P; Le Bec A; Strouthou E; Stoclet JC
    Biochem Pharmacol; 1986 May; 35(10):1743-51. PubMed ID: 2423089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs.
    Underwood DC; Kotzer CJ; Bochnowicz S; Osborn RR; Luttmann MA; Hay DW; Torphy TJ
    J Pharmacol Exp Ther; 1994 Jul; 270(1):250-9. PubMed ID: 8035322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphodiesterase 4 in macrophages: relationship between cAMP accumulation, suppression of cAMP hydrolysis and inhibition of [3H]R-(-)-rolipram binding by selective inhibitors.
    Kelly JJ; Barnes PJ; Giembycz MA
    Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):425-36. PubMed ID: 8809029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific cyclic nucleotide phosphodiesterase inhibitors differently modulate contractile kinetics in airway smooth muscle.
    Rousseau E; Dostie J; Taoudi-Benchekroun M; Cadieux A; Beaudry C; Lugnier C
    Can J Physiol Pharmacol; 1995 Dec; 73(12):1784-94. PubMed ID: 8834493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of SCA40 on human isolated bronchus and human polymorphonuclear leukocytes: comparison with rolipram, SKF94120 and levcromakalim.
    Cortijo J; Villagrasa V; Navarrete C; Sanz C; Berto L; Michel A; Bonnet PA; Morcillo EJ
    Br J Pharmacol; 1996 Sep; 119(1):99-106. PubMed ID: 8872362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of eosinophil cyclic nucleotide PDE activity and opsonised zymosan-stimulated respiratory burst by 'type IV'-selective PDE inhibitors.
    Dent G; Giembycz MA; Rabe KF; Barnes PJ
    Br J Pharmacol; 1991 Jun; 103(2):1339-46. PubMed ID: 1653070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention by phosphodiesterase inhibitors of antigen-induced contraction of guinea-pig colonic smooth muscle.
    Grous M; Barnette M
    Br J Pharmacol; 1994 Jan; 111(1):259-63. PubMed ID: 7516803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitors of phosphodiesterase IV (PDE IV) increase acid secretion in rabbit isolated gastric glands: correlation between function and interaction with a high-affinity rolipram binding site.
    Barnette MS; Grous M; Cieslinski LB; Burman M; Christensen SB; Torphy TJ
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1396-402. PubMed ID: 7791113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.